Literature DB >> 8655233

Clinical-epidemiologic study of alopecia areata.

A M Roselino1, A M Almeida, M A Hippolito, B C Cerqueira, C M Maffei, J B Menezes, R E Vieira, S L Assis, S A Ali.   

Abstract

BACKGROUND: Alopecia areata is a common disease and may be associated with autoimmune disease, atopy, Down syndrome, emotional stress, and foci of sepsis.
METHODS: Seven cases of alopecia areata were diagnosed among workers in the Water and Effluent Treatment Sector (WETS) of a paper factory, representing a 0.6% incidence, when the value for the population at large is 0.1%. Three of these workers are assigned to the WETS on a permanent basis and four provide maintenance services. One of the latter patients had alopecia areata that fully regressed. Because biologic treatment of water and effluents involves saprophytic bacteria and fungi as well as chemical substances such as acrylamide, a clinical examination and laboratory tests were performed on all workers assigned permanently to the WETS (N = 9) and on 25% of the workers, selected at random providing services to the sector (N = 14).
RESULTS: There was no association between alopecia areata and atopy, dermatophytosis, or bacteria isolated. Toxicologic evaluation revealed an acrylamide-like substance in 7 workers with alopecia areata, with a statistically significant correlation. Measures were taken at the workplace to decrease worker contact with the mists (probably containing acrylamide) in the pulp-pressing room; no other cases of alopecia areata had been detected 1 year after the study.
CONCLUSIONS: A survey of the literature did not show reports of alopecia areata as an occupational dermatosis, but our conclusion is, that this dermatosis could be due to the professional activities of the workers at the paper factory studied.

Entities:  

Mesh:

Year:  1996        PMID: 8655233     DOI: 10.1111/j.1365-4362.1996.tb01635.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  5 in total

1.  HLA antigens in individuals with down syndrome and alopecia areata.

Authors:  Juliany L Estefan; Juliana C Oliveira; Eliane D Abad; Simone B Saintive; Luis Cristóvão Ms Porto; Marcia Ribeiro
Journal:  World J Clin Cases       Date:  2014-10-16       Impact factor: 1.337

2.  Heat treatment increases the incidence of alopecia areata in the C3H/HeJ mouse model.

Authors:  Tongyu Cao Wikramanayake; Elizabeth Alvarez-Connelly; Jessica Simon; Lucia M Mauro; Javier Guzman; George Elgart; Lawrence A Schachner; Juan Chen; Lisa R Plano; Joaquin J Jimenez
Journal:  Cell Stress Chaperones       Date:  2010-06-27       Impact factor: 3.667

3.  Serum Interleukin-4 and Total Immunoglobulin E in Nonatopic Alopecia Areata Patients and HLA-DRB1 Typing.

Authors:  Enas A S Attia; Dina El Shennawy; Ashraf Sefin
Journal:  Dermatol Res Pract       Date:  2010-06-30

4.  Evaluation of the profile of alopecia areata and the prevalence of thyroid function test abnormalities and serum autoantibodies in Iranian patients.

Authors:  Hassan Seyrafi; Maryam Akhiani; Hamed Abbasi; Sahar Mirpour; Ali Gholamrezanezhad
Journal:  BMC Dermatol       Date:  2005-10-31

5.  Total serum immunoglobulin E in patients with alopecia areata.

Authors:  Ola Ahmed Bakry; Rania Mohamed Azmy El Shazly; Mohamed Ahmed Basha; Hanan Mostafa
Journal:  Indian Dermatol Online J       Date:  2014-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.